New Delhi [India], May 13: ET Markets, India's leading market watch platform, has launched ET Markets Bonds Corner, a new initiative to make bond investments more accessible to everyday Indian investors. The effort in partnership with Jiraaf is a timely collaboration, as investors are becomi
Theni (Tamil Nadu) [India], May 13: Businesses are constantly seeking smarter, faster, cost effective and more personalized ways to connect with customers, streamline operations, and scale growth. AiSA-X, a powerful, multi-functional AI assistant designed to meet the diverse needs of busines
The administration is making efforts to avoid further casualties in the illicit liquor case. The incident happened in five villages under the Majitha block in Amritsar, police said on Tuesday.
After 584 days of Hamas captivity, Israeli-American hostage Edan Alexander has returned to Israel, with Prime Minister Benjamin Netanyahu describing it as an "emotional moment."
Subic [Philippines], May 12: On May 12, 2025, Gstar Subic's module production base in the Philippines successfully launched its first N-type module. This milestone marks the official operation of the factory, signaling a new chapter in the Philippines' solar manufacturing while underscoring
New Delhi [India], May 12: India's land management system has long been a pillar of rural and urban administration, with accurate records playing a crucial role in governance, economic planning, and individual ownership rights. Traditionally, land records in India were maintained manually at
The Airport Authority of India (AAI) stated on Monday that the temporary closure of 32 airports across northern and western India for civil aircraft operations amid India-Pakistan tensions has been lifted with immediate effect.
Australian Foreign Minister Penny on Monday welcomed the understanding between India and Pakistan, emphasisng the importance of de-escalation and counter-terrorism efforts for regional peace and security.
Eli Lilly and Company announced on Monday detailed results from SURMOUNT-5, a phase 3b open-label clinical trial, evaluating the safety and efficacy of tirzepatide.